Needs review

Curated date: 2024/10/26

Curator: MyleeeA

Revision editor(s): MyleeeA

Source: Supplementary Figure 6

Description: Differentially Abundant taxa between the High Risk (HR)/Medium Risk (MR) and Low Risk (LR) groups With medication use determined using linear discriminant analysis effect size (LEfSe) analysis

Abundance in Group 1: increased abundance in Low Risk (LR) With Medication use

NCBI Quality ControlLinks
Oscillospiraceae
Lachnospiraceae
Hylemonella
Roseburia
Lysinibacillus
Vagococcus
Lachnospira
Blautia
Aggregatibacter
SMB53SMB53
RF32RF32
02d0602d06
Et0H8Et0H8

Revision editor(s): MyleeeA